Kymera Therapeutics, Inc.
KYMR
Classifica tra le azioni
#2203
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Prezzo delle azioni
$113.54
Capitalizzazione di mercato
$9.34B
Variazione (1 giorno)
5.06%
Variazione (1 anno)
87.67%
Paese
US
Scambia Kymera Therapeutics, Inc. (KYMR)
Categoria
Healthcare
Rapporto P/B per Kymera Therapeutics, Inc. (KYMR)
Rapporto P/B al October 2026 TTM: 6.95
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Kymera Therapeutics, Inc., il rapporto P/B attuale (TTM) è 6.95. Alla fine del 2023, era pari a 3.76.
Storico del rapporto P/B per Kymera Therapeutics, Inc. da 2018 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 6.95 | 92.50% |
| 2024 | 3.61 | -3.97% |
| 2023 | 3.76 | 36.99% |
| 2022 | 2.75 | -58.57% |
| 2021 | 6.63 | -31.88% |
| 2020 | 9.73 | -148.89% |
| 2019 | -19.91 | -53.72% |
| 2018 | -43.01 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| 6.251 | -10.05% |
US
|
|
| 13.2547 | 90.73% |
US
|
|
| 4.208 | -39.45% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | -11.04% |
NL
|
